Loading [Contrib]/a11y/accessibility-menu.js

Canadian Chronic Disease Surveillance System (CCDSS)

Select item(s) from each list below:




Optional:



Chart: Osteoporosis-related fracture care gap – diagnosis, age-standardized prevalence, percent who received a new osteoporosis diagnosis, age 40 years and older, CanadaTabular data available lower on summary table.02.557.51012.51517.52000–20012001–20022002–20032003–20042004–20052005–20062006–20072007–20082008–20092009–20102010–20112011–20122012–20132013–20142014–20152015–20162016–20172017–20182018–20192019–20202020–2021*2021–2022*Both sexesMalesFemalesCOVID-19 Pandemic Source: Canadian Chronic Disease Surveillance System data files provided by provinces and territories, as of July 2024.Public Health Agency of Canada, Health Infobase https://health-infobase.canada.caReset ZoomReset Zoom

For more information on the interpretation of the data please see the notes below.

Summary Table: Osteoporosis-related fracture care gap – diagnosis, age-standardized prevalence, percent who received a new osteoporosis diagnosis, age 40 years and older, Canada
Sex
Fiscal year
Prevalence (%)
95% CI
CV (%)
Counts
Flag
Both sexes
2000–2001
10.34
10.07–10.61
1.31
9,160
0
Both sexes
2001–2002
10.33
10.07–10.60
1.32
9,115
0
Both sexes
2002–2003
10.00
9.75–10.26
1.30
9,175
0
Both sexes
2003–2004
10.08
9.82–10.33
1.28
9,335
0
Both sexes
2004–2005
10.20
9.95–10.45
1.25
9,670
0
Both sexes
2005–2006
10.21
9.96–10.46
1.24
9,805
0
Both sexes
2006–2007
10.30
10.06–10.56
1.23
9,785
0
Both sexes
2007–2008
10.11
9.88–10.36
1.20
10,375
0
Both sexes
2008–2009
10.36
10.13–10.60
1.17
10,935
0
Both sexes
2009–2010
9.97
9.73–10.21
1.21
10,550
0
Both sexes
2010–2011
10.20
9.97–10.44
1.16
11,360
0
Both sexes
2011–2012
9.87
9.64–10.09
1.15
11,780
0
Both sexes
2012–2013
10.31
10.08–10.54
1.13
12,445
0
Both sexes
2013–2014
10.32
10.10–10.54
1.08
13,565
0
Both sexes
2014–2015
10.61
10.39–10.83
1.05
14,360
0
Both sexes
2015–2016
11.19
10.96–11.42
1.03
15,245
0
Both sexes
2016–2017
11.03
10.81–11.25
1.00
16,065
0
Both sexes
2017–2018
10.88
10.67–11.10
1.01
16,365
0
Both sexes
2018–2019
11.12
10.91–11.34
0.98
17,380
0
Both sexes
2019–2020
10.76
10.55–10.97
1.01
17,010
0
Both sexes
2020–2021*
11.50
11.28–11.73
0.99
17,065
0
Both sexes
2021–2022*
12.13
11.91–12.35
0.94
19,740
0
Males
2000–2001
6.45
6.11–6.80
2.70
1,590
0
Males
2001–2002
6.24
5.91–6.58
2.70
1,590
0
Males
2002–2003
6.28
5.97–6.62
2.62
1,700
0
Males
2003–2004
6.55
6.23–6.89
2.56
1,775
0
Males
2004–2005
7.04
6.71–7.38
2.42
1,975
0
Males
2005–2006
6.57
6.26–6.90
2.46
1,925
0
Males
2006–2007
6.73
6.41–7.07
2.46
1,940
0
Males
2007–2008
6.48
6.17–6.79
2.42
2,005
0
Males
2008–2009
7.07
6.75–7.39
2.28
2,270
0
Males
2009–2010
6.78
6.47–7.11
2.38
2,125
0
Males
2010–2011
6.97
6.66–7.29
2.29
2,295
0
Males
2011–2012
6.90
6.60–7.21
2.25
2,405
0
Males
2012–2013
6.85
6.55–7.16
2.24
2,475
0
Males
2013–2014
7.15
6.85–7.45
2.12
2,840
0
Males
2014–2015
7.11
6.82–7.41
2.11
2,855
0
Males
2015–2016
7.40
7.10–7.71
2.07
3,015
0
Males
2016–2017
7.41
7.12–7.71
2.01
3,285
0
Males
2017–2018
7.25
6.96–7.54
2.02
3,320
0
Males
2018–2019
7.52
7.24–7.82
1.95
3,625
0
Males
2019–2020
7.33
7.05–7.63
1.99
3,535
0
Males
2020–2021*
7.79
7.49–8.11
1.98
3,560
0
Males
2021–2022*
8.32
8.02–8.63
1.85
4,195
0
Females
2000–2001
12.52
12.13–12.92
1.58
7,570
0
Females
2001–2002
12.79
12.40–13.20
1.60
7,525
0
Females
2002–2003
12.31
11.93–12.70
1.58
7,470
0
Females
2003–2004
12.14
11.77–12.52
1.55
7,565
0
Females
2004–2005
12.10
11.74–12.47
1.52
7,700
0
Females
2005–2006
12.34
11.98–12.71
1.50
7,880
0
Females
2006–2007
12.34
11.99–12.71
1.49
7,850
0
Females
2007–2008
12.22
11.88–12.57
1.45
8,370
0
Females
2008–2009
12.26
11.92–12.61
1.42
8,670
0
Females
2009–2010
11.74
11.41–12.09
1.47
8,425
0
Females
2010–2011
11.96
11.64–12.30
1.40
9,070
0
Females
2011–2012
11.45
11.14–11.77
1.39
9,380
0
Females
2012–2013
12.23
11.90–12.56
1.36
9,970
0
Females
2013–2014
12.04
11.73–12.35
1.31
10,730
0
Females
2014–2015
12.44
12.13–12.76
1.27
11,505
0
Females
2015–2016
13.17
12.85–13.50
1.23
12,225
0
Females
2016–2017
12.87
12.57–13.18
1.20
12,780
0
Females
2017–2018
12.74
12.44–13.05
1.20
13,045
0
Females
2018–2019
12.97
12.67–13.27
1.18
13,755
0
Females
2019–2020
12.52
12.23–12.83
1.22
13,475
0
Females
2020–2021*
13.36
13.05–13.68
1.19
13,500
0
Females
2021–2022*
14.06
13.75–14.38
1.13
15,550
0
Download Detailed Table:
Osteoporosis-related fracture care gap – diagnosis, age-standardized prevalence
Download Summary Table
Notes:
  • *Many CCDSS measures, such as chronic disease incidence, were influenced by the COVID-19 pandemic. Changes in such measures may be driven by multiple factors, including (but not limited to) differences in healthcare seeking behaviour, the availability and use of healthcare services, as well as true changes in health status. As such, CCDSS measures should be used cautiously when making inferences about population health during the COVID-19 pandemic. Guidance for data users on examining the impacts of the COVID-19 pandemic on CCDSS measures can be accessed below.
  • Data suppression: Estimates are not reported when the counts are less than 10 or the coefficient of variation is greater than 33.3%.
  • Due to periodic updates of the historical surveillance data, estimates for a particular disease and year may change over time, and may not be comparable to previous editions.
  • Estimates are age-standardized to the 2011 Canadian population using unrounded counts and five-year age groups. Age-standardized estimates are useful for comparing data across years or between different geographical areas, but they do not reflect the actual impact of the disease.
  • The modernization of the Quebec billing system for fee-for-service medical services by the Régie de l'assurance maladie du Québec (RAMQ) in 2016 has resulted in a decrease in the entry of diagnostic codes in the fee-for-service medical services file. Data for 2016–2017 and subsequent years should therefore be interpreted with caution, as a slight underestimation is suspected.
  • In order to consistently provide 365 days of follow-up after a fracture, the latest year of data is not included.
  • Deaths within the 365 days of follow-up after a fracture are not included.
  • Data were not available for Yukon (prior to 2010–2011), Nunavut (prior to 2005–2006), Northwest Territories, New Brunswick (after 2019–2020) and Newfoundland and Labrador (prior to 2008–2009).
Source: Canadian Chronic Disease Surveillance System 2024
Methods: CCDSS Summary of Methods
Case definitions: CCDSS Case Definitions
COVID-19 Documentation: CCDSS COVID-19 guidance for data users

Acknowledgements

These data were made possible through collaboration between PHAC and the respective provincial and territorial governments of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Northwest Territories, Yukon, and Nunavut. No endorsement by the provinces and territories is intended or should be inferred. Provincial and territorial data were contributed to the CCDSS as of July 2024.

Did you find what you were looking for?

What was wrong?

(Don’t include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Thank you for your feedback

Report a problem or mistake on this page
Date modified:
2024-10-15